
zzso developments over the past several years are described in this zzso Efforts in phase I studies have focused on efficient zzso of maximum tolerated zzso zzso investigated for phase II trials include incorporation of multiple zzso and zzso For phase III trials, methods to reduce time or use the sample size more efficiently have been zzso However, design innovations come with costs, including possible increased risk of incorrect zzso Other recent challenging statistical developments in clinical trials relate to use of complementary outcomes such as quality of life and to associated zzso questions, including the emergence of the field of zzso 

